Aspirin prevents cancer in patients operated on these patients have a relapse and 50% greater chance of not dying from their cancer, study shows part of larger study with cancer patients.

May 18, 2005: Source: DOW

325 mg daily aspirin prevents 55% of patients with a recurrence of cancer and operated on the patients was 50% lower risk of dying from colon cancer at their study under section 75 of the 847 cancer patients followed. CELEBREX VIOXX and also gave more favorable figures shown in this study but there were too few study participants, who were using it to draw conclusions. Aspirin after surgery seems to be a cheap and safe remedy to prevent a recurrence of cancer

- DJ Regular Aspirin Use May Ward Off Colon Cancer Return Study -

By Jennifer Corbett Dooren Of DOW JONES NEWS WIRES (This article was Originally published Monday) ORLANDO, Fla.. (Dow Jones) - Cancer researchers found That regular aspirin use cuts the risk of colon cancer by half Recurrence, According To Research To Be Presented Tuesday at the American Society of Clinical Oncology's annual meeting. Researchers at Dana-Farber Cancer Institute in Boston, who lead the study, Looked at a Group of Patients That Were part of a larger research project studying the use of chemotherapy in colon cancer patients after the cancer was removed by surgery. Often Aspirin is recommended as a way to reducing cardiovascular risks like heart attacks and strokes, and previous studies have Suggested it cuts the risk of colon cancer Developing. The Study is the Largest to look at risk reduction in patiënten Already diagnosed with colon cancer. Patients Were taken from a study of 846 patients who Were enrolled in a randomized trial of two chemotherapy regimens following surgery for colon cancer. They all had stage III colon cancer had spread to lymph nodes That, but not Elsewhere in the body. The researchers interviewed patiënten about medication use and lifestyle and found 75 That, or 8.9% or patients Reported regular aspirin use. Jeffrey Meyer Hardt, an Oncologist and one of the study's authors, said aspirin users had a 55% lower risk of colon cancer enforcement Their return and a 50% lower risk of death compared with non-users. Most patiënten Either firing a 325 milligram tablet everyones day or everyother day, he said. Were patients in the study followed for "almost three years. However, Meyer Hardt said more study is Needed before a specific recommendation to take aspirin Can Be Made to colon cancer patients. The Findings he discussed with reporters Monday. Also Hardt Meyer said 41 Using the patient reported COX-2 inhibitor anti-inflammatory drugs Vioxx or Celebrex, And That Those drugs Also appeared to reducing the risk of colon cancer enforcement return in a Manner similar to aspirin. However, he said, the number of patients in the COX-2 group was too small to reach statistical significance have The Findings. Merck & Co.. (MRK) HAS since removed Vioxx from the market, after studies showed it Increased the risk for heart attacks and strokes. -By Jennifer Corbett Dooren, Dow Jones Newswires, 202-862-9294;